EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Women With Higher GCT Levels but NGT Have a Similarly High Risk for Glucose Intolerance Postpartum as Women With GDM

Lore Raets, Kim Van Hoorenbeeck, Toon Maes, DaHae Lee, Christophe De Block, Eveline Dirinck iD, Inge Van Pottelbergh, Katrien Wierckx, Annouschka Laenen iD, Annick Bogaerts, Chantal Mathieu iD, Katrien Benhalima iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf275 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Lore Raets und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Leuven 3000, Belgium. Hauptthemen laut MEDLINE: Diabetes, Gestational, Glucose Intolerance, Postpartum Period, Blood Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: KU Leuven, Novo Nordisk, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

More data are needed on the long-term postpartum metabolic risk of women with hyperglycemia in pregnancy less than gestational diabetes mellitus (GDM) based on the 2013 World Health Organization criteria.

Objective

This work aimed to determine the association of different degrees of gestational glucose intolerance (GI) on the metabolic profile and risk for GI in women and offspring 3 to 7 years postpartum.

Methods

This multicentric prospective follow-up study of the Belgian Diabetes in Pregnancy study (BEDIP-N, which was a prospective observational study) included 334 women and 296 children. Groups were stratified according to antenatal glucose challenge test (GCT) and diagnosis of GDM based on the 2013 World Health Organization criteria: normal glucose tolerant women with normal GCT (normal GCT-NGT group), NGT with abnormal GCT (abnormal GCT-NGT group), and a GDM group. Logistic regression was performed to adjust for following confounders: time since participation in BEDIP-N, ethnicity, prepregnancy body mass index (BMI), age, and current BMI.

Results

The GCT cutoff with the highest Youden index to predict GI in mothers 5.7 years postpartum was greater than or equal to 8.3 mmol/L (≥150 mg/dL). NGT women with GCT greater than or equal to 8.3 mmol/L (abnormal GCT-NGT group, n = 39) had a similarly increased risk for GI as women with GDM (n = 82) with an adjusted odds ratio of 2.87 (1.47-5.60; P = .0020) compared to the normal GCT-NGT group (n = 213). β-Cell function decreased over the different gestational glucose tolerance groups, with similar β-cell dysfunction in the GDM and abnormal GCT-NGT groups. Offspring of women with hyperglycemia less than GDM did not have an increased risk for an adverse metabolic profile postpartum.

Conclusion

NGT women with GCT greater than or equal to 8.3 mmol/L (≥150 mg/dL) in pregnancy have a similarly high risk for GI 5.7 years postpartum as women with GDM. These women also need postpartum follow-up to prevent GI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalGlucose IntolerancePostpartum PeriodBlood GlucoseHumansFemalePregnancyAdultProspective StudiesGlucose Tolerance TestFollow-Up StudiesRisk FactorsBelgium

Stichwörter der Autor:innen

gestational diabetesglucose challenge testglucose intoleranceoffspring adiposity

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Leuven 3000, Belgium.
  • Laboratory of Experimental Medicine and Paediatrics, University of Antwerp, Universiteitsplein 1, Antwerp 2610, Belgium.
  • Department of Endocrinology, Imelda ziekenhuis, Bonheiden 2820, Belgium.
  • Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Edegem 2650, Belgium.
  • Department of Endocrinology, OLV-Ziekenhuis Aalst-Asse-Ninove, Aalst 9300, Belgium.
  • Center of Biostatics and Statistical bioinformatics, KU Leuven, Leuven 3000, Belgium.

ORCID-Profile: Eveline Dirinck, Annouschka Laenen, Chantal Mathieu, Katrien Benhalima

Förderung

  • KU Leuven
  • Novo Nordisk
  • AstraZeneca
  • Mundipharma

Zitieren

APA

Raets, L., Van Hoorenbeeck, K., Maes, T., Lee, D., De Block, C., Dirinck, E., Van Pottelbergh, I., Wierckx, K., Laenen, A., Bogaerts, A., Mathieu, C., & Benhalima, K. (2025). Women With Higher GCT Levels but NGT Have a Similarly High Risk for Glucose Intolerance Postpartum as Women With GDM. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf275

Vancouver

Raets L, Van Hoorenbeeck K, Maes T, Lee D, De Block C, Dirinck E, et al. Women With Higher GCT Levels but NGT Have a Similarly High Risk for Glucose Intolerance Postpartum as Women With GDM. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf275

BibTeX
@article{Raets2025,
  author = {Raets, Lore and Van Hoorenbeeck, Kim and Maes, Toon and Lee, DaHae and De Block, Christophe and Dirinck, Eveline and Van Pottelbergh, Inge and Wierckx, Katrien and Laenen, Annouschka and Bogaerts, Annick and Mathieu, Chantal and Benhalima, Katrien},
  title = {Women With Higher GCT Levels but NGT Have a Similarly High Risk for Glucose Intolerance Postpartum as Women With GDM},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf275}
}
Kostenlos starten →